Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.94 Million EUR | 25.72% |
| 2022 | -6.65 Million EUR | 3.28% |
| 2021 | -6.88 Million EUR | -24.41% |
| 2020 | -5.53 Million EUR | -40.67% |
| 2019 | -3.93 Million EUR | 27.87% |
| 2018 | -5.45 Million EUR | -541.65% |
| 2017 | -850 Thousand EUR | 36.85% |
| 2016 | -1.34 Million EUR | 49.76% |
| 2015 | -2.67 Million EUR | -144.43% |
| 2014 | -1.09 Million EUR | -12.87% |
| 2013 | -971 Thousand EUR | -476.36% |
| 2012 | 258 Thousand EUR | 111.02% |
| 2011 | -2.34 Million EUR | 59.93% |
| 2010 | -5.84 Million EUR | 3.71% |
| 2009 | -6.07 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.43 Million EUR | 0.0% |
| 2023 Q4 | -13.54 Million EUR | 0.0% |
| 2023 Q2 | 3.77 Million EUR | 199900.0% |
| 2023 FY | -4.94 Million EUR | 25.72% |
| 2023 Q1 | 1888.00 EUR | 100.07% |
| 2022 Q4 | -2.84 Million EUR | 0.0% |
| 2022 FY | -6.65 Million EUR | 3.28% |
| 2022 Q2 | -3.97 Million EUR | -169.76% |
| 2022 Q1 | -1.47 Million EUR | 55.07% |
| 2021 FY | -6.88 Million EUR | -24.41% |
| 2021 Q1 | -296 Thousand EUR | 96.65% |
| 2021 Q2 | -592 Thousand EUR | -100.0% |
| 2021 Q4 | -3.28 Million EUR | 0.0% |
| 2020 Q1 | -824 Thousand EUR | 41.6% |
| 2020 Q3 | -4.42 Million EUR | -222.64% |
| 2020 Q2 | 3.6 Million EUR | 537.74% |
| 2020 Q4 | -8.84 Million EUR | -100.0% |
| 2020 FY | -5.53 Million EUR | -40.67% |
| 2019 FY | -3.93 Million EUR | 27.87% |
| 2019 Q4 | -1.41 Million EUR | -100.0% |
| 2019 Q3 | -705.5 Thousand EUR | 16.71% |
| 2019 Q1 | -847 Thousand EUR | 52.91% |
| 2019 Q2 | -847 Thousand EUR | 0.0% |
| 2018 Q1 | -901.5 Thousand EUR | 49.65% |
| 2018 FY | -5.45 Million EUR | -541.65% |
| 2018 Q4 | -1.79 Million EUR | 0.0% |
| 2018 Q3 | -1.79 Million EUR | -99.5% |
| 2018 Q2 | -901.5 Thousand EUR | 0.0% |
| 2017 FY | -850 Thousand EUR | 36.85% |
| 2017 Q3 | -1.79 Million EUR | -775.66% |
| 2017 Q4 | -1.79 Million EUR | 0.0% |
| 2017 Q1 | 265 Thousand EUR | 195.15% |
| 2017 Q2 | 265 Thousand EUR | 0.0% |
| 2016 FY | -1.34 Million EUR | 49.76% |
| 2016 Q3 | -278.5 Thousand EUR | -21.35% |
| 2016 Q4 | -278.5 Thousand EUR | 0.0% |
| 2016 Q1 | -229.5 Thousand EUR | 32.6% |
| 2016 Q2 | -229.5 Thousand EUR | 0.0% |
| 2015 Q2 | -393 Thousand EUR | 0.0% |
| 2015 Q4 | -340.5 Thousand EUR | 0.0% |
| 2015 Q3 | -340.5 Thousand EUR | 13.36% |
| 2015 Q1 | -393 Thousand EUR | -315.87% |
| 2015 FY | -2.67 Million EUR | -144.43% |
| 2014 Q4 | -94.5 Thousand EUR | 0.0% |
| 2014 FY | -1.09 Million EUR | -12.87% |
| 2014 Q3 | -94.5 Thousand EUR | 79.46% |
| 2014 Q1 | -460 Thousand EUR | -2258.97% |
| 2014 Q2 | -460 Thousand EUR | 0.0% |
| 2013 Q2 | -466 Thousand EUR | 0.0% |
| 2013 Q1 | -466 Thousand EUR | 0.0% |
| 2013 FY | -971 Thousand EUR | -476.36% |
| 2013 Q4 | -19.5 Thousand EUR | 0.0% |
| 2013 Q3 | -19.5 Thousand EUR | 95.82% |
| 2012 FY | 258 Thousand EUR | 111.02% |
| 2011 FY | -2.34 Million EUR | 59.93% |
| 2010 FY | -5.84 Million EUR | 3.71% |
| 2009 FY | -6.07 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Affluent Medical SA | -15.65 Million EUR | 68.402% |
| Bluelinea Société Anonyme | -1.62 Million EUR | -205.309% |
| Carmat SA | -53.86 Million EUR | 90.818% |
| Euromedis Groupe | 13.11 Million EUR | 137.726% |
| Eurobio Scientific Société anonyme | 4.83 Million EUR | 202.296% |
| Ikonisys S.A. | -2.26 Million EUR | -118.112% |
| Implanet S.A. | -6.67 Million EUR | 25.914% |
| Median Technologies SA | -22.98 Million EUR | 78.479% |
| SpineGuard SA | -4.18 Million EUR | -18.229% |
| Theraclion SA | -3.67 Million EUR | -34.585% |
| Euroapi S.A. | -189.7 Million EUR | 97.393% |
| Guerbet SA | 23.86 Million EUR | 120.724% |
| Ion Beam Applications SA | -9.11 Million EUR | 45.708% |
| Koninklijke Philips N.V. | -466 Million EUR | 98.939% |
| Sequana Medical NV | -32.56 Million EUR | 84.811% |